Chinese Academy of Medical Sciences
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
Phase 3
- Conditions
- Carcinoma, Invasive Ductal, Breast
- Interventions
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 200
- Registration Number
- NCT01126138
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)
Phase 2
Completed
- Conditions
- Poliomyelitis
- Interventions
- Biological: Inactivated Poliomyelitis Vaccine (Sabin strains)Biological: Oral Poliomyelitis VaccineBiological: Inactivated Poliomyelitis Vaccine (Salk strains).
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 500
- Registration Number
- NCT01056705
- Locations
- 🇨🇳
Pingle Center for Disease Control and Prevention, Pingle county, Guangxi, China
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains
Phase 1
Completed
- Conditions
- Poliomyelitis
- Interventions
- Biological: Inactivated Poliomyelitis Vaccine (Sabin strains)
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2010-01-14
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 130
- Registration Number
- NCT01048190
- Locations
- 🇨🇳
Hezhou Center for Disease Prevention and Control, He Zhou, Guangxi, China
A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma
- First Posted Date
- 2009-12-31
- Last Posted Date
- 2010-01-06
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 140
- Registration Number
- NCT01041482
- Locations
- 🇨🇳
Jianhui Ma, Beijing, Beijing, China
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
Phase 4
- Conditions
- HPV InfectionsPrecancerous Disease of the CervixCervical CancerHPV Related Diseases
- First Posted Date
- 2009-11-30
- Last Posted Date
- 2009-11-30
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 6200
- Registration Number
- NCT01021904
Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer
Phase 3
Completed
- Conditions
- Thoracic NeoplasmsNon-small Cell Lung Cancer
- Interventions
- Radiation: Postoperative 3D-CRT or IMRT
- First Posted Date
- 2009-04-14
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 394
- Registration Number
- NCT00880971
- Locations
- 🇨🇳
Cancer Hosiptal, Chinese Academy of Medical Sciences, Beijing, China
Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes
Phase 3
Terminated
- Conditions
- Breast Cancer
- Interventions
- Radiation: radiationRadiation: no radiation
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2016-08-08
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT00805597
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- Radiation: hypofractionation radiotherapyRadiation: conventional fractionation radiotherapy
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 810
- Registration Number
- NCT00793962
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer
- Conditions
- Rectal Neoplasms
- First Posted Date
- 2008-07-14
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 570
- Registration Number
- NCT00714077
- Locations
- 🇨🇳
Jing Jin, Beijing, Beijing, China
Effect of Montelukast on the Airway Remodeling
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- Drug: placeboDrug: singular
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT00699062
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath